Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after

Yongjun Tian1, Cheng-Fu Kuo1, Omid Akbari1

  • 1Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.

Immunity
|May 10, 2016
PubMed

Insights

Maternal hepatitis B virus (HBV) infection impairs offspring CD8(+) T cell responses, causing chronic HBV. Hepatic macrophages mediate this via PD-L1, suggesting macrophage-targeted therapies for chronic HBV.

Area of Science:

  • Immunology
  • Virology
  • Hepatology

Background:

  • Vertical transmission of Hepatitis B virus (HBV) from mother to child frequently results in chronic infection, unlike adult horizontal transmission.
  • The underlying mechanisms connecting vertical HBV transmission to chronic infection remain largely unknown.

Purpose of the Study:

  • To investigate the impact of maternal HBV infection on HBV persistence in offspring using a mouse model.
  • To elucidate the immunological mechanisms responsible for HBV persistence following vertical transmission.

Main Methods:

  • Development of a mouse model for maternal HBV infection.
  • Analysis of CD8(+) T cell responses in HBV-infected offspring.
  • Investigation of the role of hepatic macrophages and PD-L1 expression in modulating T cell responses.
  • Assessment of the therapeutic potential of hepatic macrophage depletion.

Main Results:

  • Maternal HBV infection led to impaired CD8(+) T cell responses in offspring, resulting in HBV persistence.
  • Hepatic macrophages, influenced by maternal HBV e antigen (HBeAg), upregulated PD-L1, suppressing T cell responses.
  • Depletion of hepatic macrophages restored CD8(+) T cell activation and promoted HBV clearance in offspring.

Conclusions:

  • Maternal HBV infection establishes an immunosuppressive hepatic environment in offspring, mediated by macrophages, leading to viral persistence.
  • Targeting hepatic macrophages presents a potential therapeutic strategy for treating chronic HBV infection.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
27
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
7